drugset / Trial / NCT07034677

Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism

NCT07034677

Phase 4 Recruiting 24 enrolled Lars Rejnmark
RandomizedCrossoverTriple-blindPrevention

Summary

The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.

Timeline

Start
2025-08
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Indapamide Small molecule 1.5 mg

Indications